通过诱导ITM2A+CD4T耗尽差异化,MSR1+巨细胞被动增强抗瘤免疫力
Shuai Wang1, PeiHan Wu2, Nan Xu3
1Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Hangzhou First People's Hospital, Hangzhou, China.
Hepatology (Baltimore, Md.)
|October 17, 2025
概括
这项研究表明,MSR1+巨细胞通过破坏ITM2A-ZAP70轴驱动肝细胞癌 (HCC) 中的CD4T细胞耗尽. 针对这种相互作用的抗体-药物结合物激活抗瘤免疫力,提高HCC治疗疗效.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 膜蛋白在抗瘤免疫中至关重要,但它们的具体作用尚未完全理解.
- 免疫检查点抑制剂向膜蛋白,突出其治疗潜力.
- 综合膜蛋白2A (ITM2A) 是本研究中研究的关键膜蛋白.
研究的目的:
- 探索膜蛋白在抗瘤免疫中的作用.
- 为癌症治疗确定新的膜蛋白点.
- 研究ITM2A在肝细胞癌 (HCC) 和瘤微环境 (TME) 中的功能.
主要方法:
- 使用癌症基因组图谱和国际癌症基因组联盟数据库查与预后相关的膜蛋白.
- 使用全基因,T细胞特异性和CD8T细胞特异性ITM2A淘汰小鼠用于HCK模型.
- 使用单细胞RNA测序 (scRNA-seq),TimiGP分析,分子动力学模拟和生物化学实验.
- 使用生物工程开发一种针对CD4T细胞的抗体-药物联合体 (ADC).
主要成果:
- 在HCC中,高ITM2A表达与更好的预后和免疫细胞透率的增加相关.
- ITM2A影响T细胞受体 (TCR) 在TME内透瘤淋巴细胞中的信号传递.
- 通过破坏ITM2A-ZAP70轴,MSR1+巨细胞诱导CD4 T细胞的耗尽.
- 开发的ADC (ZEA-αCD4) 显示出明显的瘤生长抑制,独立于αPDL1免疫疗法.
结论:
- 通过调节ITM2A-ZAP70轴,MSR1+巨细胞通过调节ITM2A-ZAP70轴,促进HC中CD4T细胞耗尽.
- ADC ZEA-αCD4有效地准MSR1-ITM2A相互作用,激活抗瘤免疫力.
- 这种新型的ADC方法提高了治疗疗效,可能会改善现有的免疫疗法,如αPDL1.
关键词:
CD4T CD4T CD4T CD4T CD4T CD4T CD4T CD4T CD4T CD4T CD4T CD4T CD4T CD4T CD4T在ITM2A中,它是在MSR1中,MSR1是MSR1.免疫疗法 免疫疗法巨细胞是什么?巨细胞是什么?更多相关视频
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
23.3K
06:38Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line
Published on: August 2, 2021
31.2K
相关概念视频
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
01:40Cell-mediated Immune Responses
83.4K
Overview
83.4K
01:27Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
01:24T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K